NANOG: a promising target for digestive malignant tumors
Ai-Xi Sun1, Chang-Jiang Liu1, Zi-Qin Sun1
1Ai-Xi Sun, Chang-Jiang Liu, Zi-Qin Sun, Zhi Wei, Department of Gastroenterology, The General Hospital of Jinan Military Command, Jinan 250031, Shandong Province, China.
World Journal of Gastroenterology
|October 4, 2014
Summary
NANOG, a key regulator of embryonic stem cell self-renewal, is also found in cancer stem cells. Its high expression in tumors correlates with advanced cancer stages and poor prognosis, suggesting therapeutic potential.
Area of Science:
- Stem cell biology
- Cancer research
- Molecular oncology
Background:
- NANOG is a transcription factor crucial for embryonic stem cell (ESC) self-renewal.
- Cancer stem cells (CSCs) drive tumor growth and share self-renewal properties with ESCs.
- NANOG expression is elevated in various cancers, contrasting with its low/absent levels in normal tissues.
Purpose of the Study:
- To explore the role of NANOG in cancer stem cells (CSCs).
- To investigate the potential overlap in regulatory mechanisms between ESCs and CSCs concerning NANOG.
- To assess the clinical significance of NANOG expression in cancer.
Main Methods:
- Literature review of studies on NANOG in ESCs and CSCs.
- Analysis of NANOG expression patterns in cancer versus normal tissues.
- Examination of NANOG's involvement in cancer-related pathways.
Main Results:
- NANOG is expressed in both ESCs and CSCs, but regulatory similarities are not fully understood.
- High NANOG levels in cancer tissues correlate with advanced stages and poor prognosis.
- NANOG participates in a regulatory network controlling cell fate, proliferation, and apoptosis in cancer cells.
Conclusions:
- NANOG plays a significant role in tumor transformation, tumorigenesis, and metastasis.
- NANOG's involvement in CSCs highlights its potential as a therapeutic target.
- Targeting NANOG may offer promising anti-cancer treatment strategies.
